DWTX — DOGWOOD THERAPEUTICS INC
As of Q2 2026, 7 SEC-registered investment managers reported holding DWTX (DOGWOOD THERAPEUTICS INC) in their latest 13F filings, with a combined reported value of $802.20K across 498.26K shares. That is +264.5% by share count (+361.58K shares) versus the previous quarter, while reported value moved +178.2%. Ownership is concentrated: the five largest holders account for 99.2% of reported value and the top ten for 100.0%.
Compared with the prior quarter, 3 opened new positions, 2 added to existing stakes, 1 trimmed, 2 exited entirely. 13F holdings are quarter-end snapshots, so these moves reflect positioning as of Q2 2026, not real-time trading.
DWTX is classified in the Health Care sector.
All figures on this page are computed from SEC Form 13F quarterly filings. 13F filers disclose long positions of $100,000 or more within 45 days of quarter end; short positions, options overlays and intra-quarter trades are not included, so treat the numbers as a quarterly snapshot of institutional ownership rather than real-time positioning.
| Fund | Quarter | Shares | Value | Portfolio Weight | Change |
|---|---|---|---|---|---|
| Millennium Management history | Q2 2026 | 341.81K | $550.32K | 0.00% | New |
| Geode Capital Management history | Q2 2026 | 88.30K | $142.16K | 0.00% | Add |
| Vanguard Group history | Q4 2025 | 29.95K | $124.61K | 0.00% | Add |
| BlackRock Inc history | Q2 2026 | 28.55K | $45.96K | 0.00% | Add |
| Bank of America Corp history | Q4 2025 | 9.41K | $39.17K | 0.00% | Add |
| Northern Trust Corp history | Q2 2026 | 23.78K | $38.28K | 0.00% | Hold |
| Goldman Sachs Group history | Q1 2026 | 14.60K | $30.80K | 0.00% | New |
| Marshall Wace history | Q1 2026 | 11.76K | $24.80K | 0.00% | Add |
| Citadel Advisors history | Q2 2026 | 11.74K | $18.91K | 0.00% | New |
| Morgan Stanley history | Q2 2026 | 2.22K | $3.58K | 0.00% | New |
| UBS Group AG history | Q2 2026 | 1.86K | $3.00K | 0.00% | Reduce |
| Fidelity Management & Research (FMR) history | Q1 2025 | 225 | $1.13K | 0.00% | New |
| Citigroup Inc history | Q3 2025 | 99 | $762 | 0.00% | New |
New Positions (Q2 2026)
- Millennium Management 341.81K sh · $550.32K
- Citadel Advisors 11.74K sh · $18.91K
- Morgan Stanley 2.22K sh · $3.58K
Fully Exited (vs previous quarter)
- Goldman Sachs Group sold 14.60K sh · $30.80K
- Marshall Wace sold 11.76K sh · $24.80K
Fund Position History — shares by quarter (top 13 funds)
| Fund | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | Q1 2026 | Q2 2026 |
|---|---|---|---|---|---|---|---|
| Millennium Management | — | — | — | — | — | — | 341.81K |
| Geode Capital Management | 10.93K | 14.41K | 12.82K | 15.08K | 16.78K | 79.43K | 88.30K |
| BlackRock Inc | 30 | 30 | 30 | 30 | 30 | 30 | 28.55K |
| Northern Trust Corp | — | — | — | — | — | 23.78K | 23.78K |
| Citadel Advisors | — | — | — | — | — | — | 11.74K |
| Morgan Stanley | 600 | 600 | 17.45K | 600 | 477 | — | 2.22K |
| UBS Group AG | 17.67K | 29.82K | — | — | 1.75K | 7.08K | 1.86K |
| Goldman Sachs Group | — | — | — | — | — | 14.60K | — |
| Bank of America Corp | 10 | 10 | 17 | 16 | 9.41K | — | — |
| Citigroup Inc | — | — | — | 99 | — | — | — |
| Marshall Wace | — | — | — | — | 11.65K | 11.76K | — |
| Vanguard Group | — | 11.78K | 11.78K | 22.18K | 29.95K | — | — |
| Fidelity Management & Research (FMR) | — | 225 | — | — | — | — | — |
▲ Bought Low (fund opened/added, stock rose ≥5% next quarter) ▼ Sold High (fund reduced, stock fell ≥5% next quarter)
Drag / scroll to zoom · Default shows the most recent year · Annotations come from quarterly fund actions in 13F filings · Hover a marker for details